Section 29 (New Zealand) in Bahrain
How the section 29 (new zealand) pathway operates in Bahrain.
About Section 29 (New Zealand)
New Zealand's Medsafe pathway for unapproved medicines.
How Section 29 (New Zealand) works in Bahrain
Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.
Patients in Bahrain seeking access under Section 29 (New Zealand) typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Bahrain
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.